by Truveta staff | Oct 16, 2025 | Research
In this Truveta experts spotlight, Amy Wu, Director, Partner Research and Success, analyzed recent seasonal and regional patterns in Legionella cases across the US using Truveta Data. The analysis explored how monthly counts of Legionella cases varied by US Census...
by Truveta staff | Oct 7, 2025 | Research
Doxycycline postexposure prophylaxis (doxy PEP) is now recommended by the CDC to help prevent bacterial STIs in certain high-risk groups, a prevention strategy that highlights the importance of monitoring uptake in routine care. A new study published in Sexually...
by Truveta Research | Oct 2, 2025 | Research, Research Insights
Mothers who gained more weight during pregnancy had heavier infants and mothers who lost weight during pregnancy had lighter infants. Mothers who gained less weight (particularly <15 pounds) and who lost weight during their pregnancy had increased risk of a...
by Truveta Research | Oct 2, 2025 | Research, Research Insights
Across their pregnancies, mothers had an average of 12 weight measurements, allowing us to construct a longitudinal ‘journey’ of their weight change. Mothers gained an average of 31 pounds across their pregnancies and 45% of mothers had evidence of some weight loss....
by Truveta staff | Sep 30, 2025 | Featured research, Research
Infections secondary to elevated intrarenal pressure and intrarenal backflow remain one of the most concerning complications following ureteroscopy (URS), a common procedure to examine or treat kidney stones. Even though URS is considered a safe and routine procedure,...
by Truveta staff | Sep 25, 2025 | Featured research, Research
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most serious infections, often leading healthcare providers to start powerful, broad-spectrum antibiotics like intravenous (IV) vancomycin. While vancomycin can be life-saving, unnecessary use...
